Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial

Xiaoyan Li(Tiandi Science & Technology (China)), Jinhua Leng(Chinese Academy of Medical Sciences & Peking Union Medical College), Yunlang Cai(Zhongda Hospital Southeast University), Patrick Cabri(Ipsen (France)), Dan Lu(Harbin University of Science and Technology), Yingfang Zhou(Peking University), Anna Pedret‐Dunn(Ipsen (United Kingdom)), Huaifang Li(Tongji University), Xiaofeng Shi, Renfeng Zhou(The People's Hospital of Guangxi Zhuang Autonomous Region), Hong Shi(Dalian Medical University), Xiaomao Li(Sun Yat-sen University)
Advances in Therapy
August 10, 2022
Cited by 7


Related Papers